Glucagon-Like Peptide-1 Receptor (GLP1R; GLP-1R)

Science-Business eXchange
doi 10.1038/scibx.2009.1569
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Springer Science and Business Media LLC

Related search

Glucagon-Like Peptide-1 Receptor (GLP-1R) Signaling Ameliorates Dysfunctional Immunity in COPD Patients

International Journal of COPD
EnvironmentalPublic HealthHealth PolicyMedicinePulmonaryRespiratory MedicineOccupational Health
2018English

Cardiovascular Effects of Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists

Cardiovascular Diabetology
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2014English

Second Extracellular Loop of Human Glucagon-Like Peptide-1 Receptor (GLP-1R) Differentially Regulates Orthosteric but Not Allosteric Agonist Binding and Function

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2011English

Equine Glucagon-Like Peptide-1 Receptor Physiology

PeerJ
GeneticsMolecular BiologyBiochemistryBiological SciencesMedicineAgriculturalNeuroscience
2018English

The Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Exendin-4 Reduces Cocaine Self-Administration in Mice

Physiology and Behavior
PhilosophyBehavioral NeuroscienceExperimentalCognitive Psychology
2015English

A Mechanism for Agonist Activation of the Glucagon-Like Peptide-1 (GLP-1) Receptor Through Modelling & Molecular Dynamics

Biochemical and Biophysical Research Communications
BiochemistryCell BiologyMolecular BiologyBiophysics
2018English

The Isolated N-Terminal Domain of the Glucagon-Like Peptide-1 (GLP-1) Receptor Binds Exendin Peptides With Much Higher Affinity Than GLP-1

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2003English

Pdb12 - Cardiovascular Safety of Empagliflozin Versus Glucagon-Like Peptide-1 (Glp-1) Receptor Agonists: Systematic Literature Review and Indirect Comparisons

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Effects of Gastric Inhibitory Polypeptide, Glucagon-Like Peptide-1 and Glucagon-Like Peptide-1 Receptor Agonists on Bone Cell Metabolism

Basic and Clinical Pharmacology and Toxicology
MedicineToxicologyPharmacology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy